[Cite as http://purl.org/au-research/grants/nhmrc/1009295]
Prof Ralph Martins
A/Pr Giuseppe Verdile
Prof Samuel Gandy
Brief description Alzheimer's disease (AD) is becoming more common with our growing aged population and currently no treatment exists that halts disease progress. The increasing health costs of AD underscore the need for development of any treatment that will slow or halt AD pathogenesis. By understanding the mechanisms of action of a drug [latrepirdine] that has recently shown some promise in phase II clinical trials, related drugs that are more specific and potent will be developed.
Funding Amount $AUD 512,647.64
Funding Scheme NHMRC Project Grants
Standard Project Grant